
Bryan Y. Lee
Examiner (ID: 11209, Phone: (571)270-5606 , Office: P/2445 )
| Most Active Art Unit | 2445 |
| Art Unit(s) | IWPI, 2445, 2615 |
| Total Applications | 446 |
| Issued Applications | 316 |
| Pending Applications | 28 |
| Abandoned Applications | 111 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7462124
[patent_doc_number] => 20040166097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Isolated stromal cells and methods of using the same'
[patent_app_type] => new
[patent_app_number] => 10/787506
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16103
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20040166097.pdf
[firstpage_image] =>[orig_patent_app_number] => 10787506
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/787506 | Isolated stromal cells and methods of using the same | Feb 25, 2004 | Abandoned |
Array
(
[id] => 7136032
[patent_doc_number] => 20050181035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Systemic immune activation method using non CpG nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 10/780294
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 29430
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181035.pdf
[firstpage_image] =>[orig_patent_app_number] => 10780294
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/780294 | Systemic immune activation method using non CpG nucleic acids | Feb 16, 2004 | Abandoned |
Array
(
[id] => 7107896
[patent_doc_number] => 20050108782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Transgenic RS1-/- animal and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/771151
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13526
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20050108782.pdf
[firstpage_image] =>[orig_patent_app_number] => 10771151
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/771151 | Transgenic RS1-/- animal and uses thereof | Feb 3, 2004 | Abandoned |
Array
(
[id] => 7286652
[patent_doc_number] => 20040146861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Diagnosing and treating cancer cells using mutant viruses'
[patent_app_type] => new
[patent_app_number] => 10/765520
[patent_app_country] => US
[patent_app_date] => 2004-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16869
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10765520
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/765520 | Diagnosing and treating cancer cells using mutant viruses | Jan 26, 2004 | Abandoned |
Array
(
[id] => 7250017
[patent_doc_number] => 20050142111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Method to prevent transplant rejection by stable expression of heme oxygenase-1'
[patent_app_type] => utility
[patent_app_number] => 10/750620
[patent_app_country] => US
[patent_app_date] => 2003-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7050
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142111.pdf
[firstpage_image] =>[orig_patent_app_number] => 10750620
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/750620 | Method to prevent transplant rejection by stable expression of heme oxygenase-1 | Dec 29, 2003 | Abandoned |
Array
(
[id] => 7317755
[patent_doc_number] => 20040224409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)'
[patent_app_type] => new
[patent_app_number] => 10/742920
[patent_app_country] => US
[patent_app_date] => 2003-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6984
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224409.pdf
[firstpage_image] =>[orig_patent_app_number] => 10742920
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/742920 | Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF) | Dec 22, 2003 | Abandoned |
Array
(
[id] => 7457145
[patent_doc_number] => 20040197335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Non-myeloablative tolerogenic treatment with tyrphostins'
[patent_app_type] => new
[patent_app_number] => 10/479523
[patent_app_country] => US
[patent_app_date] => 2003-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14983
[patent_no_of_claims] => 160
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20040197335.pdf
[firstpage_image] =>[orig_patent_app_number] => 10479523
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/479523 | Non-myeloablative tolerogenic treatment with tyrphostins | Dec 10, 2003 | Abandoned |
Array
(
[id] => 5648346
[patent_doc_number] => 20060134078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Method for culturing neural stem cells using hepatocyte growth factor'
[patent_app_type] => utility
[patent_app_number] => 10/536563
[patent_app_country] => US
[patent_app_date] => 2003-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8307
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134078.pdf
[firstpage_image] =>[orig_patent_app_number] => 10536563
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/536563 | Method for culturing neural stem cells using hepatocyte growth factor | Dec 1, 2003 | Abandoned |
Array
(
[id] => 5649717
[patent_doc_number] => 20060135452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Methods for treating or preventing angiogenesis-dependent symptoms'
[patent_app_type] => utility
[patent_app_number] => 10/536274
[patent_app_country] => US
[patent_app_date] => 2003-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6899
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135452.pdf
[firstpage_image] =>[orig_patent_app_number] => 10536274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/536274 | Methods for treating or preventing angiogenesis-dependent symptoms | Dec 1, 2003 | Issued |
Array
(
[id] => 5619453
[patent_doc_number] => 20060188986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Restoration of methylation states in cells'
[patent_app_type] => utility
[patent_app_number] => 10/536633
[patent_app_country] => US
[patent_app_date] => 2003-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12123
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188986.pdf
[firstpage_image] =>[orig_patent_app_number] => 10536633
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/536633 | Restoration of methylation states in cells | Nov 25, 2003 | Abandoned |
Array
(
[id] => 23467
[patent_doc_number] => 07795032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-14
[patent_title] => 'Methods for proliferating cardiomyocytes and recombinant vectors therefor'
[patent_app_type] => utility
[patent_app_number] => 10/713008
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 15
[patent_no_of_words] => 7800
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/795/07795032.pdf
[firstpage_image] =>[orig_patent_app_number] => 10713008
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/713008 | Methods for proliferating cardiomyocytes and recombinant vectors therefor | Nov 16, 2003 | Issued |
Array
(
[id] => 5912845
[patent_doc_number] => 20060127907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Method of detecting gene mutation'
[patent_app_type] => utility
[patent_app_number] => 10/533750
[patent_app_country] => US
[patent_app_date] => 2003-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9558
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127907.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533750
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533750 | Method of detecting gene mutation | Nov 6, 2003 | Abandoned |
Array
(
[id] => 7477390
[patent_doc_number] => 20040098756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Transgenic animals for use in protein expression and antibody production'
[patent_app_type] => new
[patent_app_number] => 10/696162
[patent_app_country] => US
[patent_app_date] => 2003-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14658
[patent_no_of_claims] => 113
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20040098756.pdf
[firstpage_image] =>[orig_patent_app_number] => 10696162
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/696162 | Transgenic animals for use in protein expression and antibody production | Oct 28, 2003 | Abandoned |
Array
(
[id] => 5183045
[patent_doc_number] => 20070054399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease'
[patent_app_type] => utility
[patent_app_number] => 10/595620
[patent_app_country] => US
[patent_app_date] => 2003-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 6725
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054399.pdf
[firstpage_image] =>[orig_patent_app_number] => 10595620
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/595620 | Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease | Oct 28, 2003 | Issued |
Array
(
[id] => 7142720
[patent_doc_number] => 20050118143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells'
[patent_app_type] => utility
[patent_app_number] => 10/695600
[patent_app_country] => US
[patent_app_date] => 2003-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8214
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118143.pdf
[firstpage_image] =>[orig_patent_app_number] => 10695600
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/695600 | Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells | Oct 27, 2003 | Abandoned |
Array
(
[id] => 6938541
[patent_doc_number] => 20050112104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Cardiac muscle regeneration using mesenchymal stem cells'
[patent_app_type] => utility
[patent_app_number] => 10/690435
[patent_app_country] => US
[patent_app_date] => 2003-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6482
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112104.pdf
[firstpage_image] =>[orig_patent_app_number] => 10690435
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/690435 | Cardiac muscle regeneration using mesenchymal stem cells | Oct 20, 2003 | Issued |
Array
(
[id] => 5610524
[patent_doc_number] => 20060272040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mamal obtained by implementing said method and said mamal\'s progeny'
[patent_app_type] => utility
[patent_app_number] => 10/530539
[patent_app_country] => US
[patent_app_date] => 2003-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8252
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20060272040.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530539
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530539 | Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mamal obtained by implementing said method and said mamal's progeny | Oct 13, 2003 | Abandoned |
Array
(
[id] => 7136066
[patent_doc_number] => 20040043958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Glucocorticoid enhancement of gene expression'
[patent_app_type] => new
[patent_app_number] => 10/665248
[patent_app_country] => US
[patent_app_date] => 2003-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7386
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043958.pdf
[firstpage_image] =>[orig_patent_app_number] => 10665248
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/665248 | Glucocorticoid enhancement of gene expression | Sep 18, 2003 | Abandoned |
Array
(
[id] => 5252756
[patent_doc_number] => 20070134212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells'
[patent_app_type] => utility
[patent_app_number] => 10/527587
[patent_app_country] => US
[patent_app_date] => 2003-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12189
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134212.pdf
[firstpage_image] =>[orig_patent_app_number] => 10527587
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/527587 | Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells | Sep 16, 2003 | Issued |
Array
(
[id] => 7288654
[patent_doc_number] => 20040109871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'M cell directed vaccines'
[patent_app_type] => new
[patent_app_number] => 10/660787
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23451
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20040109871.pdf
[firstpage_image] =>[orig_patent_app_number] => 10660787
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/660787 | M cell directed vaccines | Sep 11, 2003 | Abandoned |